Cargando…

Fetuin-A as a Potential Biomarker of Metabolic Variability Following 60 Days of Bed Rest

Background: Fetuin-A is a hepatokine linked to the development of insulin resistance. The purpose of this study was to determine if 60 days head-down-tilt (HDT) bed rest increased circulating fetuin-A and if it was linked to whole body insulin sensitivity (IS). Additionally, we examined whether reac...

Descripción completa

Detalles Bibliográficos
Autores principales: Ward, Kiera, Mulder, Edwin, Frings-Meuthen, Petra, O’Gorman, Donal J., Cooper, Diane
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7604312/
https://www.ncbi.nlm.nih.gov/pubmed/33192574
http://dx.doi.org/10.3389/fphys.2020.573581
_version_ 1783604118733979648
author Ward, Kiera
Mulder, Edwin
Frings-Meuthen, Petra
O’Gorman, Donal J.
Cooper, Diane
author_facet Ward, Kiera
Mulder, Edwin
Frings-Meuthen, Petra
O’Gorman, Donal J.
Cooper, Diane
author_sort Ward, Kiera
collection PubMed
description Background: Fetuin-A is a hepatokine linked to the development of insulin resistance. The purpose of this study was to determine if 60 days head-down-tilt (HDT) bed rest increased circulating fetuin-A and if it was linked to whole body insulin sensitivity (IS). Additionally, we examined whether reactive jump training (RJT) could alleviate the metabolic changes associated with bed rest. Methods: 23 young men (29 ± 6 years, 181 ± 6 cm, 77 ± 7 kg) were randomized to a control (CTRL, n = 11) or RJT group (JUMP, n = 12) and exposed to 60 days of bed rest. Before and after bed rest, body composition and [Formula: see text] were measured and an oral glucose tolerance test was performed to estimate IS. Circulating lipids and fetuin-A were measured in fasting serum. Results: Body weight, lean mass, and [Formula: see text] decreased in both groups following bed rest, with greater reductions in CTRL (p < 0.05). There was a main effect of time, but not the RJT intervention, for the increase in fetuin-A, triglycerides (TG), area under the curve for glucose (AUCG) and insulin (AUCI), and the decrease in Matsuda and tissue-specific IS (p < 0.05). Fetuin-A increased in participants who became less insulin sensitive (p = 0.019). In this subgroup, liver IS and adipose IS decreased (p < 0.05), while muscle IS was unchanged. In a subgroup, where IS did not decrease, fetuin-A did not change. Liver IS increased (p = 0.012), while muscle and adipose tissue IS remained unchanged. Conclusions: In this study, we report an increase in circulating fetuin-A following 60 days of bed rest, concomitant with reduced IS, which could not be mitigated by RJT. The amount of fetuin-A released from the liver may be an important determinant of changes in whole body IS. In this regard, it may also be a useful biomarker of individual variation due to inactivity or lifestyle interventions.
format Online
Article
Text
id pubmed-7604312
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-76043122020-11-13 Fetuin-A as a Potential Biomarker of Metabolic Variability Following 60 Days of Bed Rest Ward, Kiera Mulder, Edwin Frings-Meuthen, Petra O’Gorman, Donal J. Cooper, Diane Front Physiol Physiology Background: Fetuin-A is a hepatokine linked to the development of insulin resistance. The purpose of this study was to determine if 60 days head-down-tilt (HDT) bed rest increased circulating fetuin-A and if it was linked to whole body insulin sensitivity (IS). Additionally, we examined whether reactive jump training (RJT) could alleviate the metabolic changes associated with bed rest. Methods: 23 young men (29 ± 6 years, 181 ± 6 cm, 77 ± 7 kg) were randomized to a control (CTRL, n = 11) or RJT group (JUMP, n = 12) and exposed to 60 days of bed rest. Before and after bed rest, body composition and [Formula: see text] were measured and an oral glucose tolerance test was performed to estimate IS. Circulating lipids and fetuin-A were measured in fasting serum. Results: Body weight, lean mass, and [Formula: see text] decreased in both groups following bed rest, with greater reductions in CTRL (p < 0.05). There was a main effect of time, but not the RJT intervention, for the increase in fetuin-A, triglycerides (TG), area under the curve for glucose (AUCG) and insulin (AUCI), and the decrease in Matsuda and tissue-specific IS (p < 0.05). Fetuin-A increased in participants who became less insulin sensitive (p = 0.019). In this subgroup, liver IS and adipose IS decreased (p < 0.05), while muscle IS was unchanged. In a subgroup, where IS did not decrease, fetuin-A did not change. Liver IS increased (p = 0.012), while muscle and adipose tissue IS remained unchanged. Conclusions: In this study, we report an increase in circulating fetuin-A following 60 days of bed rest, concomitant with reduced IS, which could not be mitigated by RJT. The amount of fetuin-A released from the liver may be an important determinant of changes in whole body IS. In this regard, it may also be a useful biomarker of individual variation due to inactivity or lifestyle interventions. Frontiers Media S.A. 2020-10-19 /pmc/articles/PMC7604312/ /pubmed/33192574 http://dx.doi.org/10.3389/fphys.2020.573581 Text en Copyright © 2020 Ward, Mulder, Frings-Meuthen, O’Gorman and Cooper. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Physiology
Ward, Kiera
Mulder, Edwin
Frings-Meuthen, Petra
O’Gorman, Donal J.
Cooper, Diane
Fetuin-A as a Potential Biomarker of Metabolic Variability Following 60 Days of Bed Rest
title Fetuin-A as a Potential Biomarker of Metabolic Variability Following 60 Days of Bed Rest
title_full Fetuin-A as a Potential Biomarker of Metabolic Variability Following 60 Days of Bed Rest
title_fullStr Fetuin-A as a Potential Biomarker of Metabolic Variability Following 60 Days of Bed Rest
title_full_unstemmed Fetuin-A as a Potential Biomarker of Metabolic Variability Following 60 Days of Bed Rest
title_short Fetuin-A as a Potential Biomarker of Metabolic Variability Following 60 Days of Bed Rest
title_sort fetuin-a as a potential biomarker of metabolic variability following 60 days of bed rest
topic Physiology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7604312/
https://www.ncbi.nlm.nih.gov/pubmed/33192574
http://dx.doi.org/10.3389/fphys.2020.573581
work_keys_str_mv AT wardkiera fetuinaasapotentialbiomarkerofmetabolicvariabilityfollowing60daysofbedrest
AT mulderedwin fetuinaasapotentialbiomarkerofmetabolicvariabilityfollowing60daysofbedrest
AT fringsmeuthenpetra fetuinaasapotentialbiomarkerofmetabolicvariabilityfollowing60daysofbedrest
AT ogormandonalj fetuinaasapotentialbiomarkerofmetabolicvariabilityfollowing60daysofbedrest
AT cooperdiane fetuinaasapotentialbiomarkerofmetabolicvariabilityfollowing60daysofbedrest